Percutaneous Septal Ablation for Left Mid-ventricular Obstructive Hypertrophic Cardiomyopathy: a Case Report

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2006 Apr 12

PMID 16606458

Citations 7

Authors

Istemihan Tengiz

Ertugrul Ercan

Emin Alioglu

Ugur O Turk

Affiliations

Soon will be listed here.

Abstract

Background: Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal chamber of the ventriculum on the hemodynamic assessment.

Case Presentation: The present case represents successful percutaneous treatment with septal ablation to patient with MVOHC associated with systolic anterior motion of the mitral valve and obstruction at both the mid-ventricular and outflow levels.

Conclusion: Alcohol septal ablation has been proposed as less invasive alternatives to surgery in patients with MVOHC.

Citing Articles

Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy patients with midventricular obstruction.

Li J, Wei X Heliyon. 2024; 10(10):e31492.

PMID: 38807870 PMC: 11130719. DOI: 10.1016/j.heliyon.2024.e31492.

Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management.

Li J, Fang J, Liu Y, Wei X Clin Res Cardiol. 2023; 113(5):680-693.

PMID: 37982860 PMC: 11026226. DOI: 10.1007/s00392-023-02328-8.

Ventricular tachycardia and heart failure in a patient of mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: A case report.

Zhang X, Liu X Exp Ther Med. 2019; 18(3):2238-2242.

PMID: 31410174 PMC: 6676147. DOI: 10.3892/etm.2019.7796.

Bisoprolol Successfully Improved the Intraventricular Pressure Gradient in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy with an Apex Aneurysm due to Apical Myocardial Damage.

Tezuka A, Higo K, Nakamukae Y, Nishihara S, Kamikawa M, Shimofuku C Intern Med. 2018; 58(4):535-539.

PMID: 30333393 PMC: 6421145. DOI: 10.2169/internalmedicine.0997-18.

Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy.

OMahony C, Mohiddin S, Knight C Interv Cardiol. 2018; 9(2):108-114.

PMID: 29588787 PMC: 5808675. DOI: 10.15420/icr.2011.9.2.108.

References

Seggewiss H, Faber L . Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2002; 1(4):277-80. DOI: 10.1053/euje.2000.0032. View

Nagueh S, Ommen S, Lakkis N, Killip D, Zoghbi W, Schaff H . Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001; 38(6):1701-6. DOI: 10.1016/s0735-1097(01)01614-x. View

Nishimura R, Trusty J, Hayes D, Ilstrup D, Larson D, Hayes S . Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997; 29(2):435-41. DOI: 10.1016/s0735-1097(96)00473-1. View

Zhang W, Li Z, Zhang M, Yuan L, Guan R, Hou A . Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Chin Med J (Engl). 2002; 115(9):1283-6. View

Fighali S, Krajcer Z, Edelman S, Leachman R . Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol. 1987; 9(2):288-94. DOI: 10.1016/s0735-1097(87)80377-7. View

Watanabe H, Kibira S, Saito T, Shimizu H, Abe T, Nakajima I . Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J. 2002; 66(10):981-4. DOI: 10.1253/circj.66.981. View

Gietzen F, Schummelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S . [Interventional treatment in hypertrophic cardiomyopathy]. Herz. 2005; 30(2):102-10. DOI: 10.1007/s00059-005-2675-8. View

Kappenberger L, Linde C, Jeanrenaud X, Daubert C, McKenna W, Meisel E . Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. Europace. 2001; 1(2):77-84. DOI: 10.1053/eupc.1998.0024. View

Nakamura T, Matsubara K, Furukawa K, Azuma A, Sugihara H, Katsume H . Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol. 1992; 19(3):516-24. DOI: 10.1016/s0735-1097(10)80264-5. View

10.

Yoerger D, Weyman A . Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Rev Cardiovasc Med. 2003; 4(4):199-215. View

11.

Begley D, Mohiddin S, Fananapazir L . Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2002; 24(11):1639-44. DOI: 10.1046/j.1460-9592.2001.01639.x. View

12.

Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt H, Strick S . Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998; 31(2):252-8. DOI: 10.1016/s0735-1097(97)00508-1. View

13.

Dimitrow P, Podolec P, Grodecki J, Plazak W, Dudek D, Pieniazek P . Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2004; 94(1):31-4. DOI: 10.1016/j.ijcard.2003.03.010. View

14.

Becher H . [Contrast echocardiography: clinical applications and future prospects]. Herz. 2002; 27(3):201-16. DOI: 10.1007/s00059-002-2371-x. View

15.

Singh M, Edwards W, Holmes Jr D, Tajil A, Nishimura R . Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc. 2001; 76(8):799-802. View

16.

Fernandes V, Nagueh S, Wang W, Roberts R, Spencer 3rd W . A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol. 2005; 28(3):124-30. PMC: 6654248. DOI: 10.1002/clc.4960280305. View

17.

Wigle E, Rakowski H . Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle?. J Am Coll Cardiol. 1992; 19(3):525-6. DOI: 10.1016/s0735-1097(10)80265-7. View